Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00444 |
| Species: | Homo sapiens |
| Position : | chr5:74686000-74687899 |
| Year: | 2021 |
| Title: | Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast carcinoma |
| PMID: | 34362881 |
| MONDO: | MONDO:0006120 |
| Tissue: | Breast |
| Tissue Ontology ID: | UBERON:0000310 |
| Cell Source: | MDA-MB-231 |
| CVCL ID: | CVCL_0062 |
| Cell Type: | breast carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, RT-RT-qPCR |
| Target gene : | ENC1 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00290 | chr5:74678000-74688000 | Skin | melanoma cell | skin melanoma |